Highlights Xtacy Therapeutics Corp. Deutsche Boerse AG

Equities

TT5

CA98423G1072

Delayed Deutsche Boerse AG Other stock markets 11:31:29 03/07/2024 am IST			5-day change	1st Jan Change
0.0175 ^EUR	-2.78%		+2.94%	+40.00%

29/05	Xtacy Therapeutics Corp. Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2024	CI
17/04	Xtacy Therapeutics Corp. Reports Earnings Results for the First Quarter Ended December 31, 2023	CI

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Xtacy Therapeutics Corp. Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2024	30/05	CI
Xtacy Therapeutics Corp. Reports Earnings Results for the First Quarter Ended December 31, 2023	17/04	CI
Xtacy Therapeutics Corp. Reports Earnings Results for the Full Year Ended September 30, 2023	15/04	CI
Xtacy Therapeutics Corp. Expands MDMA Platform Pharmaceutical Grade Psychedelic Solutions to Solve Unmet Medical Needs	07/12	CI
Global Wellness Strategies Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended June 30, 2023	24/23/24	CI
Global Wellness Strategies Inc. Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2023	18/23/18	CI
Global Wellness Strategies Inc. Reports Earnings Results for the First Quarter Ended December 31, 2022	03/23/03	CI
Global Wellness Strategies Inc. Reports Earnings Results for the Full Year Ended September 30, 2022	30/23/30	CI
Global Wellness Strategies Inc. Announces Formation of Wholly Owned Pharma Subsidiary Focused on Clinical Trials	18/22/18	CI
Global Wellness Strategies Effervescent Cannabis Products Approved to Launch GWS Achieves Major Milestone Partnering with Hempsana Holdings	31/22/31	CI
Global Wellness Strategies Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended June 30, 2022	03/22/03	CI
Global Wellness Strategies Inc. Signs Custom Manufacturing Agreement with Hempsana Holdings	02/22/02	CI
Global Wellness Strategies Inc. Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2022	01/22/01	CI
Global Wellness Strategies Inc. Announces Shanti Therapeutics Mdma Clinical Trial Update	12/22/12	CI
Global Wellness Strategies Inc. Announces Their Brand KaleidoMyco to Launch Their Proprietary Fizz Tablets	12/22/12	CI
Global Wellness Strategies Inc. Reports Earnings Results for the First Quarter Ended December 31, 2021	02/22/02	CI
Global Wellness Strategies Inc. and iNGENü Sign Supply Agreement with PharmAla Biotech to Supply GMP MDMA	11/22/11	CI
Global Wellness Strategies Inc. Reports Earnings Results for the Full Year Ended September 30, 2021	03/22/03	CI
Global Wellness Strategies Inc. completed the acquisition of Shanti Therapeutics Pty Ltd from Cannvalate PTY LTD.	09/21/09	CI
Global Wellness Strategies Inc. Reports Earnings Results for the Third Quarter Ended June 30, 2021	31/21/31	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Xtacy Therapeutics Corp. Deutsche Boerse AG

Equities

TT5

CA98423G1072

Highlights

Filters